GENinCode (LON:GENI) Trading Up 4.7% – Should You Buy?

GENinCode Plc (LON:GENI) was up 4.7% during trading on Tuesday . The stock traded as high as GBX 4 ($0.05) and last traded at GBX 3.77 ($0.05). Approximately 44,586 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 801,553 shares. The stock had previously closed at GBX 3.60 ($0.05).

GENinCode Price Performance

The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.28. The firm has a 50 day moving average price of GBX 2.64 and a 200 day moving average price of GBX 2.21. The stock has a market cap of £10.82 million, a P/E ratio of -1.60 and a beta of 0.66.

GENinCode (LON:GENI) last released its earnings results on Tuesday, September 30th. The company reported GBX (1.19) earnings per share (EPS) for the quarter. GENinCode had a negative return on equity of 289.74% and a negative net margin of 228.70%. On average, analysts forecast that GENinCode Plc will post -7.1299999 EPS for the current fiscal year.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.